2868 related articles for article (PubMed ID: 22580086)
1. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
4. [The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
Baykal A; Cöplü N; Simşek H; Esen B; Gür D
Mikrobiyol Bul; 2012 Apr; 46(2):159-69. PubMed ID: 22639305
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
6. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
7. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Martinez P; Garzón D; Mattar S
Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
Ko CS; Sung JY; Koo SH; Kwon GC; Shin SY; Park JW
Korean J Lab Med; 2007 Oct; 27(5):344-50. PubMed ID: 18094599
[TBL] [Abstract][Full Text] [Related]
9. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
10. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
[TBL] [Abstract][Full Text] [Related]
11. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.
Pai H; Kang CI; Byeon JH; Lee KD; Park WB; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Oct; 48(10):3720-8. PubMed ID: 15388426
[TBL] [Abstract][Full Text] [Related]
16. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program.
Bell JM; Chitsaz M; Turnidge JD; Barton M; Walters LJ; Jones RN
J Clin Microbiol; 2007 May; 45(5):1478-82. PubMed ID: 17344367
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
